Equitec Proprietary Markets’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Equitec Proprietary Markets’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$9.5M	Buy	+43,800	New	+$4.64M	2.99%	9

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Equitec Proprietary Markets's GWPH Position: Q1 2020 in Review

Equitec Proprietary Markets opened a new position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020: 43,800 shares worth $9.5M. The stake represents 2.99% of the portfolio and ranks #9 among its holdings.

289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

Equitec Proprietary Markets held 43,800 shares of GW Pharmaceuticals Plc American Depositary Shares worth $9.5M as of Q1 2020.
GW Pharmaceuticals Plc American Depositary Shares was a new Equitec Proprietary Markets position in Q1 2020.
GW Pharmaceuticals Plc American Depositary Shares made up 2.99% of Equitec Proprietary Markets's portfolio in Q1 2020, its #9 holding.
289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Equitec Proprietary Markets's 13F filing for Q1 2020, filed 19 Apr 2021.